Clinical Trial Update: Extension Study of MT-1303 [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of the Phase 2 extension study of MT-1303 for Relapsing-remitting Multiple Sclerosis, sponsored by Tanabe Pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• MT-1303

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED